A Novel Missense Mutation in Two Families with Congenital Plasminogen Deficiency: Identification of an Ala⁶⁷⁵ to Thr⁶⁷⁵ Substitution

Summary

We used a polymerase chain reaction (PCR) strategy and restriction fragment polymorphism analysis to evaluate all 19 exons of the plasminogen (PLG) gene in a Japanese patient with congenital PLG deficiency and her family members (family C). Sequence analysis following amplification of each exon and its flanking regions showed a single G to A transition in exon 17, resulting in the conversion of an Ala⁶⁷⁵ codon (GCT) to Thr⁶⁷⁵ codon (ACT). Since this mutation generates a new Mae III site, the Mae III digestion patterns of the PCR-amplified exon 17 fragments from each family member were analyzed. In all cases, the patterns correlated with the activities and antigen levels of plasma PLG in those members. The identical G to A transition in the same codon of exon 17 was detected by a Mae III digestion experiment in another proband and her family members with congenital PLG deficiency (family K). Furthermore, 20 normal individuals examined had no Mae III restriction site at this location. We conclude that a G to A transition in exon 17 is responsible for the congenital PLG deficiency inherited in these two Japanese families.

• References

• 1 Petersen TE, Martzen MR, Ichinose A, Davie EW. Characterization of gene for human plasminogen, a key proenzyme in the fibrinolytic system. J Biol Chem 1990; 265: 6104-6111
• 2 Murray JC, Buetow KH, Donovan M, Hornung S, Motulsky AG, Disteche C, Dyer K, Swisshelm K, Anderson J, Giblett E, Sadler E, Eddy R, Shows TB. Linkage disequilibrium of plasminogen polymorphisms and assignment of the gene to human chromosome 6q26-6q27. Am J Hum Genet 1987; 40: 338-350
• 3 Cooper DN. The molecular genetics of familial venous thrombosis. Blood Rev 1991; 5: 55-70
• 4 Sottrup-Jensen L, Claeys H, Zajdel M, Petersen TE, Magnusson S. The primary structure of human plasminogen: isolation of two lysine-binding fragments and one “mini”-plasminogen (MW, 38,000) by elastase-cata-lyzed specific limited proteolysis. Prog Chem Fibriol Thrombol 1978; 3: 191-209
• 5 Forsgren M, Råden B, Israelsson M, Larsson K, Hedén L-O. Molecular cloning and characterization of a full-length cDNA clone for human plasminogen. FEBS Lett 1987; 213: 254-260
• 6 Robbins KC. Dysplasminogenemias. Prog Cardiovasc Dis 1992; 34: 295-308
• 7 Wiman B. Primary structure of the B-chain of human plasmin. Eur J Bio-chem 1977; 76: 129-137
• 8 Miyata T, Iwanaga S, Sakata Y, Aoki N. Plasminogen Tochigi: Inactive plasmin resulting from replacement of alanine-600 by threonine in the active site. Proc Natl Acad Sci USA 1982; 79: 6132-6136
• 9 Ichinose A, Espling ES, Takamatsu J, Saito H, Shinmyozu K, Maruyama I, Petersen TE, Davie EW. Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. Proc Natl Acad Sci USA 1991; 88: 115-119
• 10 Azuma H, Uno Y, Shigekiyo T, Saito S. Congenital plasminogen deficiency caused by a Ser⁵⁷² to Pro mutation. Blood 1993; 82: 475-480
• 11 Hasegawa DK, Tyler BJ, Edson JR. Thrombotic disease in three families with inherited plasminogen deficiency. Blood 1982; 60 (Suppl) (Suppl. 01) 213
• 12 Shigekiyo T, Uno Y, Tomonari A, Satoh K, Hondo H, Ueda S, Saito S. Type I congenital plasminogen deficiency is not a risk factor for thrombosis. Thromb Haemost 1992; 67: 189-192
• 13 McLean JW, Tomlinson JE, Kuang W-J, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homogeneous to plasminogen. Nature 1987; 300: 132-137
• 14 Ichinose A. Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis. Biochemistry 1992; 31: 3113-3118
• 15 Rodgers GM, Shuman MA. Congenital thrombotic disorders. Am J Hematol 1996; 21: 419-430
• 16 Girolami A, Marafioti F, Rubertelli M, Cappellato MG. Congenital heterozygous plasminogen deficiency associated with a severe thrombotic tendency. Acta Haematol 1986; 75: 54-57
• 17 Dolan G, Greaves M, Cooper P, Preston FE. Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds. Br J Haematol 1988; 70: 417-421
• 18 Schutta HS, Williams EC, Baranski BG, Sutula TP. Cerebral venous thrombosis with plasminogen deficiency. Stroke 1991; 22: 401-405
• 19 Girolami A, Sartori MT, Saggiorato G, Sgarabotto D, Patrassi GM. Symptomatic versus asymptomatic patients in congenital hypoplasminogenemia: a statistical analysis. Haematologia 1994; 26: 59-65
• 20 Scanu AM, Lawn RM, Breg K. Lipoprotein(a) and atherosclerosis: Davis conference. Ann Intern Med 1991; 115: 209-218
• 21 Lane DA, Ireland H, Olds RJ, Thein SL, Perry DJ, Aiach M. Antithrombin III: A database of mutations. Thromb Haemost 1991; 66: 657-661
• 22 Malinowski DP, Sadler JE, Davie EW. Characterization of a complementary deoxyribonucleic acid coding for human and bovine plasminogen. Biochemistry 1984; 23: 4243-4250
• 23 Marti T, Schaller J, Rickli EE. Determination of the complete amino acid sequence of porcine miniplasminogen. Eur J Biochem 1985; 149: 279-285
• 24 Gonzalez-Gronow M, Grenett HE, Fuller GM, Pizzo SV. The role of carbohydrate in the function of human plasminogen: comparison of the protein obtained from molecular cloning and expression in Escherichia coli and COS cells. Biochim Biophys Acta 1990; 1039: 269-276